Facts for Prelims (FFP)
Source: TH
Context: India has rejected the demand for ‘data exclusivity’ in ongoing FTA talks with the European Free Trade Association (EFTA).
What is Data exclusivity?
Data exclusivity is a provision that imposes a minimum embargo period, typically six years, on the use of clinical trial data generated during the testing and development of a drug. This means that other manufacturers interested in producing generic versions of the drug must either wait out the exclusivity period or generate their own data, which can be expensive and time-consuming.
This clause has been consistently rejected by India since 2008, despite pressure from the EU and EFTA. India aims to protect its generic drug industry and ensure the availability of affordable medicines.
What are Generic Drugs?
Generic drugs are pharmaceutical products that are identical or bioequivalent to brand-name drugs in terms of dosage form, strength, route of administration, quality, performance characteristics, and intended use. However, they are typically sold under their chemical name and are often less expensive than brand-name drugs.
